We have located links that may give you full text access.
Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping for a 9-mm Zone Using Optical Coherence Tomography.
Cornea 2018 October 31
PURPOSE: To evaluate the repeatability and between-machine/operator reproducibility of optical coherence tomography (RTVue-XR) for mapping corneal epithelial thickness (ET) and corneal thickness (CT) over a 9-mm zone.
METHODS: In 5 groups of eyes (normal, contact lens, dry eye, post-LASIK/PRK, and keratoconus), corneal ET and CT were evaluated in 25 areas in the following 4 regions: 1) 1 central zone within 0 to 2.0 mm diameter, 2) 8 paracentral zones from 2.0 to 5.0 mm diameter, 3) 8 midperipheral zones from 5.0 to 7.0 mm diameter, and 4) 8 peripheral zones from 7.0 to 9.0 mm diameter. Three devices with designated operators were used to obtain 3 scans per device for each eye. The repeatability, reproducibility, and coefficient of variation were calculated.
RESULTS: For all areas up to 9 mm diameter, in normal eyes, contact lens eyes, dry eyes, post- LASIK/PRK eyes, and keratoconic eyes, repeatability and reproducibility ranged from 0.7 to 1.5, 1.0 to 2.6, 0.9 to 2.0, 0.7 to 2.5, and 1.1 to 2.3 μm for ET and 1.5 to 8.3, 2.3 to 12.1, 1.7 to 14.2, 1.4 to 13.7, and 6.9 to 18.9 μm for CT, respectively. The ranges of coefficient of variation values were 1.2% to 3.0%, 1.9% to 5.5%, 1.8% to 4.3%, 1.3% to 5.2%, and 2.2% to 4.5% for ET and 0.3% to 1.2%, 0.4% to 1.8%, 0.4% to 2.1%, 0.3% to 2.0%, and 1.2% to 3.0% for CT, respectively.
CONCLUSIONS: Optical coherence tomography produced excellent repeatability and reproducibility for corneal ET and CT measurements up to a 9-mm zone in normal eyes and eyes with different corneal conditions. The CT measurements in keratoconic eyes were more variable than those in eyes with other corneal conditions.
METHODS: In 5 groups of eyes (normal, contact lens, dry eye, post-LASIK/PRK, and keratoconus), corneal ET and CT were evaluated in 25 areas in the following 4 regions: 1) 1 central zone within 0 to 2.0 mm diameter, 2) 8 paracentral zones from 2.0 to 5.0 mm diameter, 3) 8 midperipheral zones from 5.0 to 7.0 mm diameter, and 4) 8 peripheral zones from 7.0 to 9.0 mm diameter. Three devices with designated operators were used to obtain 3 scans per device for each eye. The repeatability, reproducibility, and coefficient of variation were calculated.
RESULTS: For all areas up to 9 mm diameter, in normal eyes, contact lens eyes, dry eyes, post- LASIK/PRK eyes, and keratoconic eyes, repeatability and reproducibility ranged from 0.7 to 1.5, 1.0 to 2.6, 0.9 to 2.0, 0.7 to 2.5, and 1.1 to 2.3 μm for ET and 1.5 to 8.3, 2.3 to 12.1, 1.7 to 14.2, 1.4 to 13.7, and 6.9 to 18.9 μm for CT, respectively. The ranges of coefficient of variation values were 1.2% to 3.0%, 1.9% to 5.5%, 1.8% to 4.3%, 1.3% to 5.2%, and 2.2% to 4.5% for ET and 0.3% to 1.2%, 0.4% to 1.8%, 0.4% to 2.1%, 0.3% to 2.0%, and 1.2% to 3.0% for CT, respectively.
CONCLUSIONS: Optical coherence tomography produced excellent repeatability and reproducibility for corneal ET and CT measurements up to a 9-mm zone in normal eyes and eyes with different corneal conditions. The CT measurements in keratoconic eyes were more variable than those in eyes with other corneal conditions.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app